Cortexyme to Present at 4th Annual Evercore ISI HealthCONx Conference on November 30th
November 23 2021 - 7:00AM
Business Wire
Cortexyme, Inc. (Nasdaq: CRTX) announced that Casey Lynch, chief
executive officer, co-founder, and chair, will participate in a
fireside chat at the 4th Annual Evercore ISI HealthCONx Conference
taking place virtually on Tuesday, November 30, 2021, beginning at
1:25 p.m. Eastern Time.
A webcast of the event will be accessible on the Investor
Calendar page under the News & Events heading of Cortexyme’s
investor website at ir.cortexyme.com. The webcast will be archived
at that location for 90 days.
About Cortexyme
Cortexyme, Inc. (Nasdaq: CRTX) is a clinical stage
biopharmaceutical company pioneering upstream therapeutic
approaches designed to improve the lives of patients diagnosed with
Alzheimer’s and other degenerative diseases. Cortexyme’s lead
program targets a specific, infectious pathogen called P.
gingivalis found in the brain of Alzheimer’s patients and other
organs and tied to degeneration and inflammation in humans and
animal models. The company’s causation evidence for Alzheimer’s
disease and the mechanism of its novel therapeutic has been
independently replicated and confirmed by multiple laboratories
around the world, as well as published in peer-reviewed scientific
journals. To learn more about Cortexyme, visit www.cortexyme.com or
follow @Cortexyme on Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211123005528/en/
Stacy Roughan Vice President, Corporate Communications &
Investor Relations Cortexyme, Inc. ir@cortexyme.com
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
From Apr 2023 to Apr 2024